Unilateral Ureteral Obstruction for 28 Days in Rats Is Not Associated with Changes in Cardiac Function or Alterations...

Area of Science:

• Physiology
• Nephrology
• Cardiology
• Mitochondrial Biology

Background:

• Ureteral obstruction leads to kidney damage and can impact other organs.
• The relationship between kidney dysfunction and cardiac health, known as renocardiac syndrome, requires further investigation.
• Understanding the timeline of cardiac involvement in kidney disease is crucial for timely intervention.

Purpose of the Study:

• To evaluate cardiac function and mitochondrial bioenergetics in a rat model of unilateral ureteral obstruction (UUO).
• To assess markers of kidney damage, inflammation, and fibrosis following 28 days of UUO.
• To determine if cardiac function and mitochondrial parameters are affected by established renal dysfunction.

Main Methods:

• Male Wistar rats underwent 28 days of UUO.
• Cardiac function was assessed using echocardiography.
• Kidney damage, inflammation, and fibrosis were measured via plasma markers, histology, and Western blot.
• Cardiac mitochondrial function was analyzed using high-resolution respirometry, measuring oxygen consumption and transmembrane potential.
• Activity of ATP synthase and antioxidant enzymes (glutathione peroxidase, glutathione reductase, catalase) was determined.

Main Results:

• Established renal dysfunction and fibrosis were observed in UUO rats.
• Despite renal impairment, cardiac function (e.g., ejection fraction, cardiac output) remained preserved.
• Cardiac mitochondrial function, including oxygen consumption and ATP synthase activity, was maintained.
• Antioxidant enzyme activity in the heart was not significantly altered after 28 days of UUO.

Conclusions:

• Cardiac function and mitochondrial bioenergetics are resilient in the early stages (28 days) of obstruction-induced kidney injury.
• The study suggests that renocardiac syndrome may manifest later in the progression of this condition.
• These findings highlight a potential therapeutic window to prevent or mitigate renocardiac complications.